271 related articles for article (PubMed ID: 23547267)
1. Meta-analysis of amyloid-cognition relations in cognitively normal older adults.
Hedden T; Oh H; Younger AP; Patel TA
Neurology; 2013 Apr; 80(14):1341-8. PubMed ID: 23547267
[TBL] [Abstract][Full Text] [Related]
2. Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.
Snitz BE; Weissfeld LA; Cohen AD; Lopez OL; Nebes RD; Aizenstein HJ; McDade E; Price JC; Mathis CA; Klunk WE
Am J Geriatr Psychiatry; 2015 Sep; 23(9):985-93. PubMed ID: 25746485
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.
Baker JE; Lim YY; Pietrzak RH; Hassenstab J; Snyder PJ; Masters CL; Maruff P
Alzheimers Dement (Amst); 2017; 6():108-121. PubMed ID: 28239636
[TBL] [Abstract][Full Text] [Related]
4. Cognition, reserve, and amyloid deposition in normal aging.
Rentz DM; Locascio JJ; Becker JA; Moran EK; Eng E; Buckner RL; Sperling RA; Johnson KA
Ann Neurol; 2010 Mar; 67(3):353-64. PubMed ID: 20373347
[TBL] [Abstract][Full Text] [Related]
5. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.
Hedden T; Mormino EC; Amariglio RE; Younger AP; Schultz AP; Becker JA; Buckner RL; Johnson KA; Sperling RA; Rentz DM
J Neurosci; 2012 Nov; 32(46):16233-42. PubMed ID: 23152607
[TBL] [Abstract][Full Text] [Related]
6. Global White Matter Diffusion Characteristics Predict Longitudinal Cognitive Change Independently of Amyloid Status in Clinically Normal Older Adults.
Rabin JS; Perea RD; Buckley RF; Neal TE; Buckner RL; Johnson KA; Sperling RA; Hedden T
Cereb Cortex; 2019 Mar; 29(3):1251-1262. PubMed ID: 29425267
[TBL] [Abstract][Full Text] [Related]
7. Gender differences of neuropsychological profiles in cognitively normal older people without amyloid pathology.
Zhang J; Zhou W; Wang L; Zhang X;
Compr Psychiatry; 2017 May; 75():22-26. PubMed ID: 28285181
[TBL] [Abstract][Full Text] [Related]
8. The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review.
Kelly ME; Duff H; Kelly S; McHugh Power JE; Brennan S; Lawlor BA; Loughrey DG
Syst Rev; 2017 Dec; 6(1):259. PubMed ID: 29258596
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the Mediterranean Diet on the Cognitive Functioning of Healthy Older Adults: A Systematic Review and Meta-Analysis.
Loughrey DG; Lavecchia S; Brennan S; Lawlor BA; Kelly ME
Adv Nutr; 2017 Jul; 8(4):571-586. PubMed ID: 28710144
[TBL] [Abstract][Full Text] [Related]
10. Olfaction and declarative memory in aging: a meta-analysis.
Jobin B; Roy-Côté F; Frasnelli J; Boller B
Chem Senses; 2023 Jan; 48():. PubMed ID: 37878784
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
[TBL] [Abstract][Full Text] [Related]
12. Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly.
Song Z; Insel PS; Buckley S; Yohannes S; Mezher A; Simonson A; Wilkins S; Tosun D; Mueller S; Kramer JH; Miller BL; Weiner MW
J Neurosci; 2015 Feb; 35(7):3240-7. PubMed ID: 25698758
[TBL] [Abstract][Full Text] [Related]
13. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Dubois B; Hampel H; Feldman HH; Scheltens P; Aisen P; Andrieu S; Bakardjian H; Benali H; Bertram L; Blennow K; Broich K; Cavedo E; Crutch S; Dartigues JF; Duyckaerts C; Epelbaum S; Frisoni GB; Gauthier S; Genthon R; Gouw AA; Habert MO; Holtzman DM; Kivipelto M; Lista S; Molinuevo JL; O'Bryant SE; Rabinovici GD; Rowe C; Salloway S; Schneider LS; Sperling R; Teichmann M; Carrillo MC; Cummings J; Jack CR;
Alzheimers Dement; 2016 Mar; 12(3):292-323. PubMed ID: 27012484
[TBL] [Abstract][Full Text] [Related]
15. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
[TBL] [Abstract][Full Text] [Related]
16. Tau imaging: early progress and future directions.
Villemagne VL; Fodero-Tavoletti MT; Masters CL; Rowe CC
Lancet Neurol; 2015 Jan; 14(1):114-24. PubMed ID: 25496902
[TBL] [Abstract][Full Text] [Related]
17. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
18. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
[TBL] [Abstract][Full Text] [Related]
19. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
Apostolova LG; Hwang KS; Avila D; Elashoff D; Kohannim O; Teng E; Sokolow S; Jack CR; Jagust WJ; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neurology; 2015 Feb; 84(7):729-37. PubMed ID: 25609767
[TBL] [Abstract][Full Text] [Related]
20. APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.
Liu Y; Yu JT; Wang HF; Han PR; Tan CC; Wang C; Meng XF; Risacher SL; Saykin AJ; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):127-34. PubMed ID: 24838911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
